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ABSTRACT 
The biotechnology activities development demands an intense 
academic and scientific basis, a productive sector capable of 
transforming academic research in scientific products and services, and 
the creation of an institutional environment to promote the sector’s 
development. Moreover, many biotechnology companies establish 
formal partnerships with Universities (by technological incubator) to 
expand innovative capacity coming into the market. The importance of 
biotechnology for developing countries is perceived by its ability to 
promote national development based on knowledge and innovation. In 
Brazil, the government establishes technological incubators to 
accelerate the company consolidation. In this way, it is important to 
study the relationship between the actors involved. In this context, this 
article aims to analyze the relationship between a technological 
incubator and a biotech company. To do so, the qualitative approach 
was adopted to reach the objective. Interviews with incubator’s 
employees of a Brazilian University and biotechnology company’s 
managers were conducted. The results show that the company-
incubator interaction promoted projects approval which were able to 
support new researches development and to purchase production  
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equipment. Incubated companies have higher chances of survival in the market from 
the interaction with University, through the technological incubator. The relationship 
between the incubator and the biotech company is considered a fundamental 
condition for biotechnology activities development.  
Keywords: biotechnology development, technological incubator, company-incubator 
relationship. 
 
1. INTRODUCTION 
 The use of sequencing genes technique of living organisms is making 
significant advances in cellular and molecular biology in the past decades. Such 
progress allowed the development of biotechnology, which led the biological 
sciences segment to be considered a business initiative, with the transformation of 
scientific and technological knowledge into technologies or products. In this sense, 
biotechnology represents a group of technologies that employ biological basis to 
make or modify products and processes, as well as to generate new services of high 
impact on various sectors (BRASIL, 2007). From manipulation of smaller structures 
that compose living organisms, biotechnology operates, mainly, in the fields of food, 
energy generation, environmental pollution prevention and bioremediation 
(ZECHENDORF, 1999). 
 The biotechnology tools are useful for creating innovations and contribute to a 
more sustainable development, such as the reduction of pollution in the environment 
(ZECHENDORF, 1999; VALLE; SANTOS, 2008). Regarding the treatment of 
contaminated areas, for instance, bioremediation is one of the alternatives more 
ecologically balanced, with faster results and less costly to industries 
(ZECHENDORF, 1999). More specifically, bioremediation can be defined as the 
utilization of living organisms to decontaminate or reduce the pollutants content in the 
environment (SCHENBERG, 2010). 
 The importance of biotechnology for developing countries is illustrated by the 
capacity to promote national development based on knowledge and innovation, 
generation jobs and supporting economy (VALLE; SANTOS, 2008). Besides that, its 
applications have contributed to the structuring of new social and economic systems. 
Therefore, the biotechnology development has strategic importance in the 
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consolidation of a knowledge-based economy and sustainable development 
(BRASIL, 2007). Biotechnology has been pointed as a great new promise to the 
Brazilian economic development, highlighting the significance of studies in this 
subject (CUNHA; MELO, 2006). 
 In this context, there should be a channel between knowledge production and 
its transformation in product and process, where the result of this articulation is the 
creation of technological innovations that will provide better conditions for economic 
and social sustainability (FREITAS et al., 2012). It should be noted that the term 
innovation involves not only the creation of new products or services in companies, 
but also the creation of new institutional arrangements between institutional spheres 
that provide the necessary conditions for innovation (ETZKOWITZ, 2003). Thus, the 
development of the biotechnology sector requires a complex system of interaction 
among different agents (large and small companies, universities, research centers, 
technology incubators, financial institutions, regulators, government, consumers, 
public agencies) establishing a diversity of integrations due to the   cooperation 
needs and the market competition forms (DRUCK, 2011). 
 Particularly, technological incubators appear in the convergence of public and 
private interests seeking to systematize the transition from the development of new 
technologies to its commercialization, which exemplifies the emergence of a science 
politics, technology and innovation (ETZKOWITZ, 2002). Therefore, this article aims 
to analyze the relationship between a technological incubator and a biotechnology 
company. To achieve this goal, we used a qualitative approach. We believe that is 
relevant to recognize and to correlate the perceptions around the relationship 
between the actors involved in order to generate a better understanding about the 
biotechnology activity development in the country. 
 This article is divided into five sections, besides its introduction. At first, we 
performed a review of biotechnology and bioremediation. In the second, we argue 
about business incubators. In the third, we described the methodology used in this 
research. The next part presents the analysis of data, structured into categories. 
Finally, in the fifth part, finals considerations are made as well as study limitations 
and possibilities for further research. 
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2. BIOTECHNOLOGY 
 The term biotechnology can be defined as the science and technology 
application to the biological basis for change, improve, develop or develop products, 
process or organisms, as well as to provide services and knowledge production (VAN 
BEUZEKOM; ARUNDEL, 2009). In other words, the Organization for Economic Co-
operation and Development (OECD, 1999) considers biotechnology the application of 
technical and scientific principles to treatment of materials by biological agents in 
order to obtain products and services. 
 Biotechnology is not characterized as a discipline, but presents a complex 
multidisciplinary basis, where the main subjects are basic science, involving 
molecular and cellular biology, biochemistry, genetics, microbiology, engineering, 
chemistry, computer science, among others (CANCHUMANI, 2006; DRUCK, 2011). 
Thereby, biotechnology is formed by a set of technology skills, produced by scientific 
and technological knowledge developed in these various disciplines (KREUZER; 
MASSEY, 2002). Therefore, it is an activity which is characterized by high 
dependence of research in basic sciences, by multidisciplinarity and complexity, by 
applying in different production sectors, by high risks involved and by research high 
costs of its products or services (DRUCK, 2011). 
 Biotechnology has occupied a prominent role in the world market, since its 
tools are useful in resolving scientific issues, in developing new products and 
services, and in achieving goals desired by society (e.g. the pollution reduction in the 
environment) (ZECHENDORF, 1999; VALLE; SANTOS, 2008). In this sense, it has 
great potential in the development of more sustainable alternatives, especially in the 
food, energy production, environmental pollution prevention and bioremediation 
segments. Biotechnology is able to disseminate new and clean sources of recyclable 
energy, new methods to detect and treat environmental contamination as well as 
develop innovative products and processes more environmental friendly compared to 
the ones used nowadays (KREUZER; MASSEY, 2002). Zechendorf (1999) argues 
that the application prospects of biotechnological methods are excellent, because 
these methods are often less expensive than conventional technologies, for instance, 
in detoxification of effluents. 
 A biotechnology company is the one that presents technological application, 
using living organisms as major commercial activity in biological systems or 
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processes, in research and development, in the production process or in the 
provision of services (HODGSON, 2006). Then, Science begins to be understood as 
a business initiative, from the scientific and technological knowledge transformation 
into technologies or products. One of the features that differentiate the biotechnology 
industry – from other high-tech industries – is the activities intensity in research and 
development, and the period required for an innovation to reach the market. These 
characteristics forces companies to establish more flexible strategies for innovation, 
growth and survival (HALL; BAGCHI-SEM, 2001; CANCHUMANI, 2006). 
 In this context, biotechnology has been used as support for technological 
innovations, contributing to a high turnover of products in the market, for business 
competitiveness and socioeconomic development (SCHENBERG, 2010). In Brazil, 
the Biotechnology Development Policy was approved in 2007 as an initiative to 
biotechnology activities. This policy aims to provide an environment conducive to 
creation of innovative biotechnology products and processes, as well as to foster 
greater efficiency in national productive structure; the increasing capacity to innovate 
of companies; the study of new technologies; the business generation; and the 
Brazilian exports expansion (BRASIL, 2007). Biotechnology is, then, presented as a 
promising opportunity to accelerate national development based on knowledge and 
innovation, job creation, regional development, increase exports, reduce imports, and 
clean production with less environmental impact (BRASIL, 2007; VALLE; SANTOS, 
2008). 
 In the past years, the Brazilian scientific community developed a capacity to 
handling new techniques of biotechnology (e.g., recombinant DNA technology and 
genomics and proteomics research). Currently, biotechnology integrates the 
productive base of different national economy sectors, affecting approximately 3% of 
gross domestic product (DRUCK, 2011). According to an Overview of Biotechnology 
in the World and in Brazil, produced by the Brazilian Agency for Industrial 
Development (ABDI, 2010), the country’s Southeast region is responsible for almost 
half of total national biotechnology research. The Brazilian South region, in turn, 
owns 23.5% of the research and overcomes the Southeast concerning the diversity 
of subjects studied. Still, according to the scenario, 57% of research in biotechnology 
is directly financed with funds from the Federal Government – 46% of these linked to 
federal universities (ABDI, 2010). 
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2.1  Bioremediation 
 An industrialization consequence is the waste release, accidentally or 
intentionally, improperly in the ecosystem, contaminating the atmosphere, the 
hydrosphere, the soil and the groundwater and aquifers (WHITE; CLAXTON, 2004; 
SILVA-JUNIOR; VARGAS, 2007). Among the techniques that are been developed for 
waste management and areas decontamination, it is possible to apply physical, 
biological and chemical processes together in order to minimize contamination of 
organic compounds in security acceptable levels, according to the each country 
legislation (REDDY et al., 1999). Though, the technique selection varies with the 
contaminant, the local characteristics, regulatory requirements, operation costs and 
time constraint (RISER-ROBERT, 1998; REDDY et al., 1999). Khan et al. (2004) say 
that the choice of effective remediation techniques is complex, however, is crucial to 
the decontamination success to the impacted area. 
 Considering that conventional technologies for environmental remediation are 
generally inadequate to minimize heavy metal concentration in contaminated 
effluents, bioremediation is presented as an interest alternative (SCHENBERG, 
2010). Bioremediation is a remediation technique developed by biotechnology, 
characterized by presenting a decontamination technique, where the degradation of 
toxic contaminants is accomplished mainly by the use of microorganisms (that have 
physiologic and metabolic ability) to degrade such substances (ATLAS, 1981). This 
phenomenon occurs due to the presence of degrading microorganisms in most 
ecosystems, where contaminants may serve as a source of organic carbon. 
Bioremediation uses the physiological competence with degrading potential of these 
microorganisms. It may be considered as a low-cost-effective and environmentally 
acceptable alternative (JACQUES et al., 2007). 
 Bioremediation has several strategies to biodegrade the contaminant on the 
presence of microorganisms. We can highlight the bio augmentation among them. It 
is a strategy that helps to improve the capacity of a contaminated matrix in order to 
remove contaminants by addition of an isolated strain or consortia of microorganisms 
potentially degrading. The inoculum to be used can be selected directly from the 
contaminated area, as well as from other impacted environments (FANTROUSSI; 
AGATHOS, 2005). Gentry et al. (2004) believe that the basic premise for 
bioaugmentation success, besides the inoculums added to the system, would be the 
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metabolic capacity of the population introduced to assimilate the genetic diversity 
from the contaminated area, leading to an expansion of its biodegradation 
competence.  
 In this context, it is clear that biotechnology can assume a very important role, 
mainly regarding prevention of pollution and bioremediation of contaminated areas. 
Bioremediation is widely used, comprising  degradation of pharmaceutical waste, 
biotransformation of paper into ethanol, decontamination of mining wastewater 
contaminated with heavy metals, and oils, among others. Zechendorf (1999) argues 
that, in 1999, bioremediation already had significant economic efficiency when 
compared to decontamination traditional technologies, representing a reduction of 
65% to 85% in the final cost. In fact, bacteria, microalgae, fungi, yeasts, and plants 
(considering industrial fermentation wastes) can, in principle, serve as a cheap 
material for water contaminated by metals bioremediation. Also, the aqueous and 
solid wastes treatment of industrial, agricultural and domestic origin offers a number 
of opportunities to apply a wide range of bioremediation techniques (ZECHENDORF, 
1999). 
3. INCUBATOR 
 The biotechnology projects require that companies of this sector conduct 
ongoing efforts aiming the modernization of productive activities, human resource 
capacity and accumulation and flow of knowledge from the cooperation with 
knowledge producing institutes (CANCHUMANI, 2006). The development of 
biotechnology activities demand a strong academic and scientific basis, a productive 
sector capable of transforming the academic and scientific production into products 
and services and the creation of an institutional environment that offers, at the same 
time, reliability to the entrepreneur and to all society, against the risks involved in 
investigative and productive activities in the biotechnology field (DRUCK, 2011). 
Moreover, the institutional environment must provide the necessary conditions to 
formation of cooperation nets and interaction for generation, transfer and use of 
knowledge and/or technology. The main motivation for creating these relationships is 
the complementation technique, since its search is required in activities involving 
varied and in-depth knowledge (CUNHA; MELO, 2006). 
 According to  Biotechnology Development Policy (BRASIL, 2007), companies 
currently in the country using biotechnology to develop their technological chain to 
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generate their products, process and services rely on technical and scientific support 
offered by higher education institutes, state institutes, research institutes, active in  
generation of technologies, goods and biotechnological services. In 2009, Brazil had 
108 private biotech companies; most of them had formal partnership with scientific 
and technological institutions, highlighting the importance of university-industry 
interaction to expand the innovation capacity that comes to the market (DRUCK, 
2011). The universities, research centers, science and technology parks and 
business incubators begin to act as science business active participants (PISANO, 
2006). 
 From this perspective, Vedovello and Figueiredo (2005) argue that 
technological business incubators with small and medium companies operating 
incubated in a productive segment and sharing a similar cultural and socioeconomic 
environment may constitute a new approach to public policies in favor of innovation 
and industrial competitiveness. According to the National Association of Promoting 
Entities of Innovative Enterprises (Anprotec), business incubators are innovative 
enterprises promoters, aiming to support entrepreneurs so they can develop 
innovative ideas and transform them into success companies (graduated 
companies). Some companies, after leaving the incubator, will be creating direct and 
indirect employment with incomes and assets that will contribute to the economic 
growth (LALKAKA, 2002) as successful graduated companies. In this sense, the 
business incubators are playing increasingly important roles in the innovation 
scenario, bringing together different political and actors, and channeling efforts and 
resources to promote a more proactive economic environment, supporting a more 
sustainable and competitive socioeconomic development (VEDOVELLO; 
FIGUEIREDO, 2005). 
 Regarding biotechnology, Canchumani (2006) identified that incubators and 
universities are considered a facilitating factor for formation and development stage 
of biotech companies. According to the author, incubators and universities are seen 
by the incubated company owners as training resources for the technological base of 
companies, both concerning human resources, as technical resources. All 
companies that were surveyed recognize the importance of research and 
development, and the cooperation with institutions that produce knowledge, as well 
as the strategic value of qualified human resources from these institutions. 
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4. METHOD 
 This research aims to analyze the relationship between an incubated 
biotechnology company and a biotechnology technological incubator linked to a 
University. Thus, it is classified as a qualitative research, which is an exploratory 
methodology that enables better insight and understanding of the problem context 
(MALHOTRA, 2006). According to Roesch (1999), the exploratory study is 
characterized as a research strategy which aims to examine a phenomenon present 
in its own context. The technological incubator choice was by convenience, because 
of the access ease to primary data collection. On the other hand, the company’s 
choice was intentional, due to its representativeness to the incubator and in the 
bioremediation field. The company is incubated since its formation in 2003, and even 
beyond the incubation period, the company maintains its status as incubated, as well 
as projects with the incubator and the University. 
 Interviews were performed as data collection technique, and developed with 
aid of a semi-structured script with open questions. The script had questions about 
the interaction between University-company, the relation between incubator and 
incubated and from the perspective of biotechnology activity in the country for the 
next years. The initial contact with the incubator happened on a technical visit. After 
this visit, we conducted the interview with the technological incubator manager, who 
provided information about the incubated company. Later, we get in touch with the 
company by telephone in order to invite their managers to participate of this study. 
The interviews were conducted at the company administrative department. 
 The incubated company administrative and financial manager, the marketing 
manager and the production manager were interviewed, as well as the incubator 
manager. The interviews were granted in June/July 2012, and each one lasted 
approximately 30 minutes. The interviews were recorded by audio recording and 
then, they were transcribed. After these procedures, we used the technique of 
content analysis for data processing. The data collected in the interviews are 
reported and compared with the literature chosen. To preserve the incubator and the 
company identities, we chose to use fictitious names on the results analysis. So, the 
participants were called as G1, G2, G3 and G4 to preserve their identity, where G1, 
G2 and G3 represent the incubated company and G4 the incubator. 
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5. RESULTS 
5.1. The biotech company  
 The studied company develops and sells biotechnology based products as an 
alternative to the treatment of municipal and industrial sewage, animal manure and 
domestic sewage. Biosul (a fictional name) has a collection of over 2,000 selected 
microorganisms isolated and identified. Associated with knowledge and domain on 
conducting biotechnological production processes, these are their greatest asset and 
differential. The company is located in Southern Brazil and it distributes its product in 
Brazil, Argentina and Spain. Biosul was founded in 2003 originated from PhD thesis, 
in order to apply the biotechnology concepts in practice, as well as bring scientific 
knowledge to everyone. Since its foundation, the company is tied to a technological 
incubator from a Federal University. By the relationship with the incubator, it has 
submitted and approved projects to support research and development of new 
studies, and to purchase machinery and equipment to the new production process. 
 Nowadays, Biosul has five employees in it staff, working directly at the 
company headquarters, plus a net of distributors and technical assistance spread in 
Brazil and in the foreign countries. Considering staff, the managers interviewed are: 
administrative and financial (G1); production (G2); and, marketing (G3). G1 is the 
Biosul founder and he has Ph.D. in cellular and molecular biology. G2 is studying 
Ph.D. in biotechnology developing a product for contaminates soil by hydrocarbons 
treatment. G2 is a company employee since 2009. G3 is a chemical technician, with 
degree in chemistry and management. G3 is company employee since 2005; since 
2008, G3 is also a Biosul partner. 
 At this point, it is possible to notice that employees have a career in 
biotechnology, in academic research or market research, and professional 
experience involving environmental impacts minimization through biological 
treatment. This trajectory can justify employees identification with the company goals. 
As the speech of G3, “I see the company today, we got this structure, setting up a 
new team and we see a huge potential […] I believe in the product and see 
opportunities to the company.” G2 claims that he has pretentions to continue working 
on Biosul, as we can see in this interview passage: “the company has a small staff, 
but we cheer for this team to grow and continue to be a team part”. 
  
INDEPENDENT JOURNAL OF MANAGEMENT & PRODUCTION (IJM&P) 
http://www.ijmp.jor.br                     v. 5, n. 1, October – January 2014. 
ISSN: 2236-269X   
DOI: 10.14807/ijmp.v5i1.135
237 
 Biosul products reduce the degradation time of contaminated areas, without 
releasing chemicals in the environment (as observed in traditional remediation 
techniques). According to G2, “what you have is more chemical […] it can be used 
but, sooner or later, may cause damage. Bioremediation is a clean technology of 
remediation”. Unlike other bioremediation companies, Biosul products are developed 
using microorganisms from the native biota. Such fact can be confirmed from the 
report of G2: “hence, we always try to work with local microorganisms, so there is no 
damage when it is added to the environment”. 
 The use of Biosul’s products accelerates the waste degradation, reducing the 
degradation time, minimizing the costs and, consequently, generating greater 
affordability to their customers. The technical assistance available from the product 
purchase is highlighted as a fundamental element of the company’s strategy, since it 
is necessary to make the application accurately and follow up the residue 
degradation. This fact is corroborated by G3: “the analysis that we follow is a job that 
requires 100% of post sales; it [the bioremediation] is the kind of job that monitoring 
is essential to make it work”. Therefore, orientations are made to customers so they 
can understand how the product works. Distributor’s teams are spread in the country 
and they are trained to pass this information to customers, as well as to know how to 
evaluate the products results. 
5.2. The Incubator 
 The technological incubator of biotechnology (TIB) is located in the Brazil 
Southern region and it is linked to a Federal University. The TIB started its activities 
in 1992, with two incubated companies. In a general way, TIB seeks to establish, 
develop and strengthen small business and technological projects in biotechnology 
and related sectors. The incubator goal is to stimulate the creation and strengthening 
of companies, offering a suitable environment and promoting technical and 
managerial skills, by training and teaching activities of human resources highly 
qualified in their areas. The TIB is installed within the University, designed to stages 
of development and production up to eight companies incubated simultaneously. 
Also, the incubator offers a meeting room for shared use and an amphitheater with 
capacity for 115 guests. 
 The incubator installation at the University promotes potential research 
activities as job and resources generators encourage new companies in the 
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biotechnology segment by furthering interaction among University and companies, 
create jobs, train human resources, and promote the direct connection between 
scientific and technologic development with its incorporation to production means. 
Furthermore, the incubator has a team, coordinated by a university teacher and 
managed by a university employee (G4). It also has a secretary, internships and 
external consultants. G4 has a degree in biology and, since 2000, works directly at 
incubator. About the beginning of the incubator, G4 says: 
“it was a year [reference to 2000] of courses and selections, business plan 
course, management techniques, visits to incubators, strategies, planning, 
and they select 10 employees that could be reallocated to the management 
of the University’s incubator and to support technology transfer issues, so I 
went to the biotechnology incubator”. 
 The company incubation process has three steps: selection of companies, 
pre-incubation and incubation. Periodically, the incubator opens a call for companies 
to select those who will join the incubation process. These candidates must prepare 
a business plan submitted with proper documentation for proposal submission to the 
incubation call. After analyzing the business plan, the approved one joins the TIB for 
the pre-incubation phase. The pre-incubation is intended to improve the business 
plan, with support from the incubator, and to formally build the biotechnology 
company. G4 explains that, during this phase, the entrepreneur “spends six months 
with our consultant, consulting one hour per week, and the guy will be focused on 
those parts of the business plan that required more attention, needed more 
information. He will learn how to make a market assessment and how to use financial 
spreadsheets”. 
 At the end of pre-incubation phase, the business plan is assessed in terms of 
its technical, economic and market feasibility and moves to the incubation phase (or 
the company will be disconnected from the incubator). G4 says: “at the end of six 
months if [ ] the business viability is proven with as much data as possible and the 
company was created, because it needs a national register of legal person, then [the 
entrepreneur] signs the incubation contract”. During the incubation phase, the 
company develops, produces and sells its products. The incubation time is tree 
years, and it can be extended for more three years. This time is longer than the 
incubation time of other incubators, however, according to G4, “who knows some 
incubator will say [ ] six years, this is nonsense! Actually, it is not. If you think that in 
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biotechnology sector, the average time to get into the market is about ten years, six 
years is nothing extraordinary. In some cases, we have to extend it a little bit.” 
 Currently the TIB has eight companies incubated and it is preparing a call to 
select four projects. The incubated companies operate in the health segment, 
agribusiness and environment. The services offered by TIB to incubated companies 
includes: support to prepare the business plan; orientation for seeking funding and 
research and development project management; business management consulting; 
training for specialized technical development; assistance in finding new 
technologies; encourage on interaction with external sources of capacity and 
knowledge; access to laboratories of the University’s biotechnology center; and, 
supportive administrative services, such secretarial, reception, internet access and 
cleaning services. Moreover, G4 complements: “we [the incubator] are now seeking 
the certification for business incubators [ ] today are a few hundred items that are 
selection, evaluation, a series of items, business plan that the incubator has to be 
structured. This certification will give a minimum quality pattern to incubators”. 
5.3. Analysis and Interpretation 
 Using the content analysis technique, some elements were identified from 
respondent’s reports. These elements are considered most relevant and frequent to 
the studied circumstance: the interaction between University and company; the 
relation between the incubated company and the technological incubator; the 
government role in the biotechnology development; and, the biotechnology sector 
perspective in the country for the next years. Business incubators had become 
incorporated into Brazil policy agenda from the late 1980s and the beginning of the 
1990s (VEDOVELLO; FIGUEIREDO, 2005). The Federal University linked to the 
studied incubator has others incubators divided into sectors. The proximity to specific 
laboratories of each sector allows a greater synergy among staff training, the 
research and the incubated companies. G4 explains that in early 1990s, 
“the University realized that there was a trend of sectorial incubators [ ], the 
biotechnology incubator was being created, the computing one, the medicine 
one, the University was structuring its strategy of incubators, with 
normalization of the University so each one won’t make different things. Why 
results are better in terms of sectorial incubators? Because, in 
biotechnology, I have to offer a laboratory module, I have to consider the 
characteristics of biotechnology. So the incubator being sectorial suits better 
for the incubated company. So, we can work better for characteristics of the 
sector”. 
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 Also, G4 states: “the incubator was created especially because the interaction 
lack between the biotechnology center and the productive sector”. This statement 
confirms the argument from Valle and Santos (2008). Those authors pointed out that 
the biotechnology development demands a strong academic and scientific base 
creation as well as a productive sector capable of transforming this academic and 
scientific production into goods, processes and services. From this perspective, it is 
understood that the TIB has the goal of facilitating the integration of the products, 
processes and services that were developed in biotechnology researches in the 
University with the biotechnology industry. According to G4: “our incubator’s mission 
is to fund and support the development of biotechnology companies, where the 
business matter comes… That’s the reason why it exists and works until today”. 
 The interaction University-company is shown as an essential condition for the 
biotechnology activities development by company managers. G3 argues: “the 
interaction with the University ends up being beneficial to the company, the fact of 
being a company with the University helps with credibility, especially for a startup, 
with a new service in the market, it is important to have this support”. G2 
complements saying: “information is critical, what is happening, trends, on the 
innovation field, everything goes through the University, so it is good to have this 
bond. And the University is very well regarded”. Accordingly, from the reports, it is 
possible to notice that the incubator aims to assist and support the incubated 
companies in product development and in the company’s organization itself. 
 Biosul maintains patents for its products with the University. Pisano (2006) 
says that much of the interaction discussion between universities and biotechnology 
industries is about the patents, when, in fact, the central issue should be the 
knowledge in this patent. The main problems caused by the technological 
development of companies focus on the difficulty of managing the knowledge 
inherent on research activities (CUNHA; MELO, 2006). Still, the authors suggest that 
the incubators should encourage the creation and development of companies 
through the further entrepreneur training in their technical and managerial aspects. 
G4 indicates: “entrepreneurs [from biotechnology companies] are good technically, 
but they don’t know how to sell the product, or even how to approach a customer, 
nothing about finances, or market, they don’t know how to do it”. Further, G4 
complements: 
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 “the entrepreneurship at the University begins with someone [the 
entrepreneur] having a good idea, but we have to elaborate it. There is a 
strategy for each level. This person has to make a business plan, the 
University has a program that teaches how to do it, he has consulting, he will 
reach the end, with a business plan, then he can go to an incubator where 
he will develop that business plan, where he will use the research and 
development laboratory. He will be around the place where innovation 
happens; he got a better success chance this way.” 
 In this way, we can verify that incubated companies have higher chances of 
survival in the market from the interaction with University, through the incubator, as 
reported by G1: “outside the incubator is complicated. The biotechnology interaction 
with the University is essential”. In turn, G2 comments: “we had support from 
economists, consultants, business plan; they taught us how to do it. I used to work 
only on research and after this training I learned from how to issue a note to how 
manage the company”. The Biosul managers agreed that incubation was necessary 
for their company and for products development. The incubated company 
performance can be improved by the existence of a services package and financial 
resources provided to or by technological incubators (VEDOVELLO; FIGUEIREDO, 
2005). G1 ensures: “the company incubation is necessary, [ ] so biotechnology won’t 
develop outside the incubator, it simply does not happen”. 
 It is possible to notice that company incubation is essential due to some 
characteristics of the sector, such as high costs of research and commercialization of 
products or services, necessity of qualified people, and necessity of adequate 
infrastructure. G4 exposes: “the sector characteristics are: ‘the high costs of 
equipment, long developing time, also the physical areas that need to be appropriate 
to the operations’”. From the recognition of the sector characteristics, G4 adds that 
“this [the sector characteristics] we as incubators need to know, the hardest 
bottlenecks for companies, we as incubators need to attend”. 
 Due to the high cost to create and structure the company and the product 
maturation period, G1 claims: “biotechnology grows slowly, because biotechnology 
demands a lot of research and very expensive equipment”. This report is supported 
by Canchumani (2006), because the author considers the consolidation of 
biotechnology companies on the market slow. Hall and Bagchi-Sem (2001) follow the 
same line by state that one of biotechnology industry characteristics is the long 
period required for the innovations developed in research laboratories come available 
in the market. Thus, G1 ensures: “the researches in biotechnology could last 15 
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years until it results in a product […] the incubation time has to be bigger too”. G4 
reinforces: “10 years is, in average, the normal time for biotechnology, but the 
incubator has the function to accelerate the processes. So, if everyone works 
straight, it is possible to develop in less time”. 
 According to Vedovello and Figueiredo (2005) and Lalkaka (2002), the 
incubators must provide to companies a proper infrastructure and a supportive 
environment needed to foment new ventures. The studied incubator is located in a 
permanent spot inside the University. There are labs for products research and 
development, meeting rooms, reception room, as well as rooms for the administrative 
sector of each incubated company. G1 says that this infrastructure facilitates the 
biotechnology activities development, since “public universities are well structured 
and got more equipment already”. However, the incubators should not be considered 
just as a shared enterprise space, but as people and organizations nets (HACKETT; 
DILTS, 2004). 
 Regarding human resources, G4 informs that incubated companies 
entrepreneurs are highly educated, “80% has masters or Ph.D. degree, and the team 
is not composed 100% of doctors because the ones with master degree are still 
studying for Ph.D., but it is really an entrepreneur with high qualification”. 
Nonetheless, the Biotechnology Panorama in the World and in Brazil (ABDI, 2010) 
has pointed bottlenecks related to attracting and fixing those professionals to the 
sector, including low wage and incipient training in management. This fact can be 
explained by G1’s report: “the researches have to keep up. After finishing the Ph.D., 
it is very hard to develop a product, so they have to find other ways to make money. 
They end up not being able to develop the product and abandon it [the idea]”. Biosul 
emerged from the G1’s Ph.D. thesis, and it only managed to grow because, as G2 
said, “it was born incubated”. 
 The company’s relationship with the University is extremely important. 
According to G4, “given the number of companies, there is low number of employees 
for companies involved with biotechnology”. G2 states: “most of the staff working with 
us [at Biosul] came from there [the University]. It is a proof”. G3 tells that he is doing 
his Ph.D. in biotechnology area, and got a project approved linking his job and his 
studies. G2 claims: 
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 “when Biosul leaves the incubator, we want to keep the research and 
development with the University, because the University is the best source 
for information and human resources. The connection with the incubator and 
the University allows our company to submit projects to finance machinery, 
equipment, supplies, researches, human resources etc.”  
 Regarding incentives, the government has provided significant amount of 
resources to promote the research and development in biotechnology, through 
agencies as the Coordination of Improvement of Higher Education Personnel 
(CAPES), the National Council of Science (CNPq) or another governmental agency. 
According to G2, “all equipment was acquired through public money, using projects”. 
The resources devoted to research and development in biotechnology were, 
somewhat, sufficient. However, according to G3, “if you look the calls, resources 
aren’t for bioremediation. It is for other biotechnology areas… biotechnology 
sometimes is focused on cellular and molecular biology, nanotechnology, transgenic. 
Nowadays, the environmental treatment is still unknown”.  
 Moreover, the relationship with governmental agencies as pointed as 
paradoxical, because it presents lots of incentives and, at the same time, innumerous 
obstacles. It should be noted that one of the Biotechnology Development Policy 
objectives established in 2007 includes “the establishment of appropriate 
environment for the development of innovative biotechnological products and 
processes” (BRASIL, 2007, Art. 1º). Nonetheless, G1 says: 
 “the relation with the govern is paradoxical. At the same time that they give 
a lot of resources for research and development for biotechnology, the State 
structure forbids the commercialization, there is no normative, no regulation 
for our biological products […] at the same time everyone thinks that it is 
genius to use biotechnology to develop the country, there is no legislation for 
it, and that prevent us to sell what we produce”. 
 The main difficulties identified to biological products development were the 
laws related to products manufacture and commercialization. The animal, industrial 
wastewater and sanitary and domestic areas force the company to comply the 
legislation of three environmental government agencies: Agriculture, Livestock and 
Supply Ministry (MAPA), Health Surveillance National Agency (ANVISA) and the 
Environment and Renewable Natural Resources Brazilian Institute (IBAMA). 
According to G1,  
“the legislations are conflicting, because IBAMA demands some tests to 
approve the product while ANVISA demands others. So? IBAMA claims that 
if you do not register it with them, you cannot sell. ANVISA claims that 
registering it with them, allows you to sell. The legislation for biological 
products is the biggest obstacle in this country”. 
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 The respondents maintain a positive view when asked about the expectation 
of biotechnology activity in Brazil, as G1 says: “the future is very promising”. G3 says: 
“biotechnology is an area that will grow a lot in this country”. This argument can be 
justified by the Biotechnology Development Policy. This Brazilian legislation aims to 
provide appropriate conditions to the development of innovative biological products, 
processes and services (Brasil, 2007). Concerning bioremediation, G3 claims: “the 
bioremediation is still unknown, but it is getting better. There is always a new project 
with governmental funds to biotechnology. I think that this segment is growing and 
has huge potential”. G2 says that the segment future belongs to the ones that are 
studying at the University and that put their ideas into practice, betting that it will 
come true in the incubated companies. He adds that for the biotechnology activity 
development, “we must take the knowledge to everyone, the scientific knowledge, to 
really perform applied biotechnology”. 
6. FINAL CONSIDERATIONS 
 This article aimed to analyze the relationship between the technological 
incubator and a biotech company. To this end, we conducted interviews with the 
coordinator of a technological incubator for biotechnology sector and managers of a 
biotechnology company incubated. It was found many gaps in scientific knowledge 
production and biotechnology application, since biotech companies face technical-
scientific, productive, financial or commercial problems that still cannot be fully 
solved. However, respondents agree that the incubator represents a possibility to 
overcome these gaps and ensure greater longevity for the company in the market. 
The relationship between Universities and biotechnology companies is considered a 
fundamental condition for development of these activities, due mainly to high initial 
capital necessary for company’s opening and the long time required developing the 
product. 
 The technological incubator represents a notorious way for Biosul to keep in 
touch with the Federal University. This institution is an important source of 
information, trends, innovations and human resources. Respondents stated that the 
connection with the University allowed the company to submit and approve projects 
to support and develop new researches as well as to purchase machines and 
equipment for production process. However, it was considered consensus that 
government agencies stimulate the research and biotechnology development, and, at 
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the same time, end up creating barriers and contradictions for companies in this 
sector. Furthermore, it was found that the main obstacles to create biotechnology 
companies are difficulty in raising resources, lack of infrastructure necessary to 
manufacture the products, government heavy regulation and lack of skilled 
managers. 
 We believe that the sample size is the central limitation of this research. Data 
collected represents only views, opinions and perceptions of the respondents. Thus, 
other participants from other companies in the biotechnology industry and other 
technological incubators could assign different answers to the questions. Therefore, 
this study does not intend to generalize the achievements. For future research, we 
suggest researching the opinions and the perceptions of a larger number of experts; 
to analyze the relationship of incubators and incubated companies in other regions of 
Brazil or other countries; to interview experts from other knowledge areas; or still, to 
analyze publication level in national and international journals to verify if there is 
indeed a research increase on the topic. 
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